Sunshine Biopharma, Inc. (SBFM)
SBFM Stock Price Chart
Explore Sunshine Biopharma, Inc. interactive price chart. Choose custom timeframes to analyze SBFM price movements and trends.
SBFM Company Profile
Discover essential business fundamentals and corporate details for Sunshine Biopharma, Inc. (SBFM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
15 Feb 2022
Employees
52.00
CEO
Steve N. Slilaty
Description
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.
SBFM Financial Timeline
Browse a chronological timeline of Sunshine Biopharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 4 Nov 2025
Earnings released on 12 Aug 2025
EPS came in at -$0.39 falling short of the estimated -$0.11 by -254.55%, while revenue for the quarter reached $9.41M , missing expectations by -22.23%.
Earnings released on 15 May 2025
EPS came in at -$0.44 , while revenue for the quarter reached $8.90M .
Earnings released on 5 Nov 2024
EPS came in at -$0.94 falling short of the estimated $9.00 by -110.44%, while revenue for the quarter reached $8.44M , missing expectations by -32.52%.
Earnings released on 16 Aug 2024
EPS came in at -$9.94 falling short of the estimated -$7.40 by -34.32%, while revenue for the quarter reached $9.30M , meeting expectations.
Stock split effective on 8 Aug 2024
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 20 May 2024
EPS came in at -$40.00 falling short of the estimated -$1.04 by -3.75K%, while revenue for the quarter reached $7.54M , beating expectations by +7.73%.
Stock split effective on 17 Apr 2024
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 28 Mar 2024
EPS came in at -$100.00 falling short of the estimated -$3.00 by -3.23K%, while revenue for the quarter reached $7.68M , beating expectations by +25.90%.
Earnings released on 13 Nov 2023
EPS came in at -$80.00 falling short of the estimated -$0.06 by -133.23K%, while revenue for the quarter reached $5.96M , missing expectations by -2.33%.
Earnings released on 11 Aug 2023
EPS came in at -$40.00 surpassing the estimated -$160.00 by +75.00%, while revenue for the quarter reached $5.56M , beating expectations by +11.22%.
Earnings released on 10 May 2023
EPS came in at -$160.00 , while revenue for the quarter reached $4.89M .
Earnings released on 4 Apr 2023
EPS came in at -$3.00K , while revenue for the quarter reached $3.94M .
Earnings released on 7 Nov 2022
EPS came in at -$160.00 , while revenue for the quarter reached $132.81K .
Earnings released on 3 Aug 2022
EPS came in at -$60.00 , while revenue for the quarter reached $150.31K .
Earnings released on 6 May 2022
EPS came in at -$0.23 , while revenue for the quarter reached $122.65K .
Earnings released on 21 Mar 2022
EPS came in at $0.19 , while revenue for the quarter reached $85.12K .
Stock split effective on 9 Feb 2022
Shares were split 1 : 200 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Nov 2021
EPS came in at -$1.59 , while revenue for the quarter reached $50.38K .
Earnings released on 9 Aug 2021
EPS came in at -$1.20 , while revenue for the quarter reached $52.87K .
Earnings released on 11 May 2021
EPS came in at -$2.82 , while revenue for the quarter reached $40.06K .
Earnings released on 30 Mar 2021
EPS came in at -$0.63 , while revenue for the quarter reached $28.01K .
Earnings released on 11 Nov 2020
EPS came in at -$0.50 , while revenue for the quarter reached $17.15K .
SBFM Stock Performance
Access detailed SBFM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.